Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: A cluster randomized trial.
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Purpose Guidelines recommend administering antibiotics within 1 h of sepsis recognition but this recommendation remains untested by randomized trials. This trial was set up to investigate whether survival is improved by reducing the time before initiation of antimicrobial therapy by means of a multifaceted intervention in compliance with guideline recommendations. Methods The MEDUSA study, a prospective multicenter cluster-randomized trial, was conducted from July 2011 to July 2013 in 40 German hospitals. Hospitals were randomly allocated to receive conventional continuous medical education (CME) measures (control group) or multifaceted interventions including local quality improvement teams, educational outreach, audit, feedback, and reminders. We included 4183 patients with severe sepsis or septic shock in an intention-to-treat analysis comparing the multifaceted intervention (n = 2596) with conventional CME (n = 1587). The primary outcome was 28-day mortality. Results The 28-day mortality was 35.1% (883 of 2596 patients) in the intervention group and 26.7% (403 of 1587 patients; p = 0.01) in the control group. The intervention was not a risk factor for mortality, since this difference was present from the beginning of the study and remained unaffected by the intervention. Median time to antimicrobial therapy was 1.5 h (interquartile range 0.1-4.9 h) in the intervention group and 2.0 h (0.4-5.9 h; p = 0.41) in the control group. The risk of death increased by 2% per hour de…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One failed to achieve a difference in time-to-antimicrobials between arms [120].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [120]
In the citing paper
“Observational studies do, however, suggest that mortality may increase after intervals exceeding 3–5 h from hospital arrival and/or sepsis recognition [98, 111, 119, 120].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [120]
In the citing paper
“Source control of infectious foci was associated with improved survival in recent observational and cluster randomised studies [120, 263, 264].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [120]
Citations
Cites
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Self-citationSurviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621 · cited 3×
“This contrasts the conclusion of a meta-analysis which failed to demonstrate that antimicrobial therapy within 1 h after severe sepsis recognition improves survival and therefore questioned the evidence base for the respective SSC guideline recommendations [10].”
Self-citationKumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109 · cited 1×
“5% for each 1 h delay in starting AT [2], a 28-day mortality of 34.”
Audit and feedback: effects on professional practice and healthcare outcomes
Ivers, N., Jamtvedt, G., Flottorp, S., Young, J. M., Odgaard-Jensen, J., French, S. D., O'Brien, M. A., Johansen, M., Grimshaw, J., & Oxman, A. D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000259.pub3 · Cited by 5,485 · cited 1×
“may be less effective if baseline performance is already good [16].”
Ferrer, R., Martin-Loeches, I., Phillips, G., Osborn, T. M., Townsend, S., Dellinger, R. P., Artigas, A., Schorr, C., & Levy, M. M. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000330 · Cited by 1,480
Self-citationGaieski, D. F., Mikkelsen, M. E., Band, R. A., Pines, J. M., Massone, R., Furia, F. F., Shofer, F. S., & Goyal, M. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cc4824 · Cited by 970
Comparison of Evidence of Treatment Effects in Randomized and Nonrandomized Studies
Ioannidis, J. P. A. (2001) · JAMA · doi:10.1001/jama.286.7.821 · Cited by 919 · cited 1×
“Such studies are prone to overestimation of the measured effects, bias due to secular trends, or the Hawthorne effect [11, 12].”
Ferrer, R. (2008) · JAMA · doi:10.1001/jama.299.19.2294 · Cited by 741
Levy, M. M., Artigas, A., Phillips, G. S., Rhodes, A., Beale, R., Osborn, T., Vincent, J.-L., Townsend, S., Lemeshow, S., & Dellinger, R. P. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70239-6 · Cited by 548
Self-citationSterling, S. A., Miller, W. R., Pryor, J., Puskarich, M. A., & Jones, A. E. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001142 · Cited by 434 · cited 1×
“However, a recent metaanalysis showed no increase in mortality with a delay in AT therapy up to 5 h after severe sepsis recognition [14].”
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Self-citationSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Self-citation2023 Update on Sepsis and Septic Shock in Adult Patients: Management in the Emergency Department
Guarino, M., Perna, B., Cesaro, A. E., Maritati, M., Spampinato, M. D., Contini, C., & De Giorgio, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093188 · Cited by 294
Forsetlund, L., O'Brien, M. A., Forsén, L., Mwai, L., Reinar, L. M., Okwen, M. P., Horsley, T., & Rose, C. J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003030.pub3 · Cited by 268
Rationalizing antimicrobial therapy in the ICU: a narrative review
Timsit, J.-F., Bassetti, M., Cremer, O., Daikos, G., de Waele, J., Kallil, A., Kipnis, E., Kollef, M., Laupland, K., Paiva, J.-A., et al. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05520-5 · Cited by 266
Veiga, R. P., & Paiva, J.-A. (2018) · Critical Care · doi:10.1186/s13054-018-2155-1 · Cited by 203
Antimicrobial-associated harm in critical care: a narrative review
Arulkumaran, N., Routledge, M., Schlebusch, S., Lipman, J., & Conway Morris, A. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05929-3 · Cited by 175
Intra-abdominal sepsis: new definitions and current clinical standards
Hecker, A., Reichert, M., Reuß, C. J., Schmoch, T., Riedel, J. G., Schneck, E., Padberg, W. M., Weigand, M. A., & Hecker, M. (2019) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-019-01752-7 · Cited by 178
jomo: A Flexible Package for Two-level Joint Modelling Multiple Imputation
Quartagno, M., Grund, S., & Carpenter, J. (2019) · The R Journal · doi:10.32614/rj-2019-028 · Cited by 140
“Finally, it has been used in applications, particularly, but not exclusively, for imputation of missing data in individual patient data meta-analyses (e.g., (Bloos et al., 2017)).”
MethodFleischmann-Struzek, C., Mikolajetz, A., Schwarzkopf, D., Cohen, J., Hartog, C. S., Pletz, M., Gastmeier, P., & Reinhart, K. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5377-4 · Cited by 140
Self-citationAbdulla, A., Dijkstra, A., Hunfeld, N., Endeman, H., Bahmany, S., Ewoldt, T. M. J., Muller, A. E., van Gelder, T., Gommers, D. A. M. P. J., & Koch, B. C. P. (2020) · Critical Care · doi:10.1186/s13054-020-03272-z · Cited by 151
for the MEDUSA study group, Thomas-Rüddel, D. O., Poidinger, B., Lindner, M., Weiß, M., Reinhart, K., & Bloos, F. (2018) · Critical Care · doi:10.1186/s13054-018-2050-9 · Cited by 143
“Data collection and laboratory diagnostics Data collection and definitions were as described previously [11, 12].”
BackgroundMethodInfluentialSelf-citationGrumaz, S., Grumaz, C., Vainshtein, Y., Stevens, P., Glanz, K., Decker, S., Hofer, S., Weigand, M. A., Brenner, T., & Sohn, K. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003658 · Cited by 135
A Critical Analysis of the Literature on Time-to-Antibiotics in Suspected Sepsis
Weinberger, J., Rhee, C., & Klompas, M. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa146 · Cited by 125
Saeed, K. B. A., Wilson, D. C., Bloos, F., Schüetz, P., van der Does, Y., Melander, O., Hausfater, P., Legramante, J. M., Claessens, Y.-É., Amin, D., et al. (2019) · Critical Care · doi:10.1186/s13054-019-2329-5 · Cited by 135
Self-citationthe SepNet Critical Care Trials Group, Elke, G., Bloos, F., Wilson, D. C., Brunkhorst, F. M., Briegel, J., Reinhart, K., Loeffler, M., Kluge, S., Nierhaus, A., et al. (2018) · Critical Care · doi:10.1186/s13054-018-2001-5 · Cited by 127
“Nevertheless, earlier indicators of developing organ dysfunction or a deteriorating host response are essential in order to guide the most appropriate therapeutic intervention at the earliest opportunity [26, 27].”
BackgroundSelf-citationAssociation Between Time to Source Control in Sepsis and 90-Day Mortality
Reitz, K. M., Kennedy, J., Li, S. R., Handzel, R., Tonetti, D. A., Neal, M. D., Zuckerbraun, B. S., Hall, D. E., Sperry, J. L., Angus, D. C., et al. (2022) · JAMA Surgery · doi:10.1001/jamasurg.2022.2761 · Cited by 112
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08361-1 · Cited by 141
Self-citationAn approach to antibiotic treatment in patients with sepsis
Martínez, M. L., Plata-Menchaca, E. P., Ruiz‐Rodríguez, J. C., & Ferrer, R. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2020.01.47 · Cited by 136
“The authors found a 2% increase in mortality for every hour of antibiotic delay in more than 4,000 patients with sepsis and septic shock (41).”
BackgroundPost-operative abdominal infections: epidemiology, operational definitions, and outcomes
Bassetti, M., Eckmann, C., Giacobbe, D. R., Sartelli, M., & Montravers, P. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05841-5 · Cited by 114
Rapid Next-Generation Sequencing–Based Diagnostics of Bacteremia in Septic Patients
Grumaz, C., Hoffmann, A., Vainshtein, Y., Kopp, M., Grumaz, S., Stevens, P., Decker, S., Weigand, M. A., Hofer, S., Brenner, T., et al. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2019.12.006 · Cited by 114
Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action
Worldwide Antimicrobial Resistance National/International Network Group (WARNING) Collaborators, Sartelli, M., Barie, P. S., Coccolini, F., Abbas, M., Abbo, L. M., Abdukhalilova, G., Abraham, Y., Abubakar, S., Abu‐Zidan, F. M., et al. (2023) · World Journal of Emergency Surgery · doi:10.1186/s13017-023-00518-3 · Cited by 135
Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007075 · Cited by 117
Self-citationAudit and feedback: effects on professional practice
Ivers, N., Yogasingam, S., Lacroix, M., Brown, K. A., Antony, J., Soobiah, C., Simeoni, M., Willis, T. A., Crawshaw, J., Antonopoulou, V., et al. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000259.pub4 · Cited by 78
Sepsis hysteria: excess hype and unrealistic expectations
Singer, M., Inada-Kim, M., & Shankar‐Hari, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32483-3 · Cited by 91
Rüddel, H., Thomas-Rüddel, D. O., Reinhart, K., Bach, F., Gerlach, H., Lindner, M., Marshall, J. C., Simon, P., Weiß, M., Bloos, F., et al. (2022) · Critical Care · doi:10.1186/s13054-022-03901-9 · Cited by 87
Self-citationThomas-Rüddel, D. O., Hoffmann, P., Schwarzkopf, D., Scheer, C., Bach, F., Komann, M., Gerlach, H., Weiß, M., Lindner, M., Rüddel, H., et al. (2021) · Critical Care · doi:10.1186/s13054-021-03776-2 · Cited by 81
Self-citationSociety for Maternal-Fetal Medicine Consult Series #67: Maternal sepsis
Shields, A. D., Plante, L. A., Pacheco, L. D., & Louis, J. M. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.05.019 · Cited by 95
Source control in the management of sepsis and septic shock
Waele, J. J. D., Girardis, M., & Martín‐Loeches, I. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06852-5 · Cited by 78
Asner, S. A., Desgranges, F., Schrijver, I. T., & Calandra, T. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.03.003 · Cited by 82
for the ABISS-Edusepsis Study group, Ferrer, R., Martínez, M. L., Gomà, G., Suarez, D. L., Álvarez-Rocha, L., de la Torre, M. V., González, G., Zaragoza, R., Borges-Sa, M., et al. (2018) · Critical Care · doi:10.1186/s13054-018-2091-0 · Cited by 69
“In a cluster randomized trial to evaluate the effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality, the MEDUSA study group [36] found no association between the intervention and impact on time to empiric antibiotic or mortality; however, the authors concluded the intervent…”
BackgroundSelf-citationSartelli, M., Tascini, C., Coccolini, F., Dellai, F., Ansaloni, L., Antonelli, M. M., Bartoletti, M., Bassetti, M., Boncagni, F., Carlini, M., et al. (2024) · World Journal of Emergency Surgery · doi:10.1186/s13017-024-00551-w · Cited by 77
Diagnosis and Treatment of Candidemia in the Intensive Care Unit
Bassetti, M., Giacobbe, D. R., Vena, A., & Wolff, M. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1693704 · Cited by 72
Nunnally, M., Ferrer, R., Martin, G. S., Martín‐Loeches, I., Machado, F. R., Backer, D. D., Coopersmith, C. M., Deutschman, C. S., Antonelli, M. M., Hellman, J., et al. (2021) · Intensive Care Medicine Experimental · doi:10.1186/s40635-021-00400-z · Cited by 64
Self-citationSepsis-Update: Definition und Epidemiologie
Bracht, H., Hafner, S., & Weiß, M. (2019) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/a-0625-5492 · Cited by 58
“Aktuelle deutsche Daten Die aktuellsten Daten aus Deutschland zeigten in der MEDUSA-Studie [18] 2011–2013 (Interventionsgruppe/Kontrollgruppe) eine Verteilung des Fokus der Infektion in fallender Häufigkeit: Pneumonie (35,4/37,7%), intraabdominelle Infektionen (35,7/ 35,8%), urogenitale Infektionen (12,1/13,6%) und pr…”
BackgroundInfluentialSartelli, M., Barie, P. S., Agnoletti, V., Al‐Hasan, M. N., Ansaloni, L., Biffl, W. L., Buonomo, L. A., Blot, S. I., Cheadle, W. G., Coimbra, R. S. M., et al. (2024) · World Journal of Emergency Surgery · doi:10.1186/s13017-024-00552-9 · Cited by 68
“A 2017 trial [135] demonstrated that achievement of surgical source control was significantly related to 28-day mortality, with 1% increased mortality per hour of delay to source control.”
BackgroundReview: sepsis guidelines and core measure bundles
Desposito, L., & Bascara, C. J. (2024) · Postgraduate Medicine · doi:10.1080/00325481.2024.2388021 · Cited by 46
“An RCT study in 2017 in Germany involving 4183 patients revealed no affect on 28-day mortality between treatment times of 1.5 hours versus 2 hours [28].”
InfluentialPiperacillin-Tazobactam in Intensive Care Units: A Review of Population Pharmacokinetic Analyses
El‐Haffaf, I., Caissy, J.-A., & Marsot, A. (2021) · Clinical Pharmacokinetics · doi:10.1007/s40262-021-01013-1 · Cited by 47
Determinants of sepsis knowledge: a representative survey of the elderly population in Germany
the vaccination60+ study group, Eitze, S., Fleischmann-Struzek, C., Betsch, C., & Reinhart, K. (2018) · Critical Care · doi:10.1186/s13054-018-2208-5 · Cited by 43
“Delays in treatment are associated with increased risk of mortality [4].”
BackgroundSelf-citationWaele, J. J. D., & Dhaese, S. A. M. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1568239 · Cited by 47
“Three major determinants in which sepsis management can make a difference include inappropriate antibiotic therapy, delayed antibiotic therapy, and the lack of source control [53].”
BackgroundPiperacillin–tazobactam as alternative to carbapenems for ICU patients
Pilmis, B., Jullien, V., Tabah, A., Zahar, J., & Brun‐Buisson, C. (2017) · Annals of Intensive Care · doi:10.1186/s13613-017-0334-x · Cited by 44
“Secondly, the authors did not take into account the severity of underlying diseases, delays to antimicrobial treatment and effectiveness source control, which are all major predictors of outcome [70].”
BackgroundКirov, М. Y., Владимирович, К. В., Николаевич, П. Д., Щеголев, А. В., Babaev, M. A., Belotserkovskiy, B. Z., Bykov, A. O., Gritsan, A. I., Кулабухов, В. В., Kulikov, A. V., et al. (2023) · Annals of critical care · doi:10.21320/1818-474x-2023-4-7-42 · Cited by 44
Bakterielle Sepsis: Diagnostik und kalkulierte Antibiotikatherapie
Richter, D., Heininger, A., Brenner, T., Hochreiter, M., Bernhard, M., Briegel, J., Dubler, S., Grabein, B., Hecker, A., Krüger, W. A., et al. (2017) · Der Anaesthesist · doi:10.1007/s00101-017-0363-8 · Cited by 37
“im Jahr 2017 [106] den Gesamtdatensatz von MEDUSA mit insgesamt 4000 Patienten aus und untersuchten u.”
BackgroundAntimicrobial Stewardship in the ICU
Murphy, C. V., Reed, E. E., Herman, D. D., Magrum, B., Beatty, J. J., & Stevenson, K. (2022) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1740977 · Cited by 39
Clinical controversies in abdominal sepsis. Insights for critical care settings
Martín‐Loeches, I., Timsit, J., Léone, M., Waele, J. J. D., Sartelli, M., Kerrigan, S. W., Azevedo, L. C. P., & Einav, S. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.05.023 · Cited by 41
A Data-Driven Approach to Predicting Septic Shock in the Intensive Care Unit
Yee, C. R., Narain, N. R., Akmaev, V. R., & Vemulapalli, V. (2019) · Biomedical Informatics Insights · doi:10.1177/1178222619885147 · Cited by 38
Roquilly, A., Chanques, G., Lasocki, S., Foucrier, A., Fermier, B., de Courson, H., Carrié, C., Déserts, M. D. D., Gakuba, C., Constantin, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1441 · Cited by 39
Piedmont, S., Goldhahn, L., Swart, E., Robra, B., Fleischmann-Struzek, C., Somasundaram, R., & Bauer, W. (2024) · Infection · doi:10.1007/s15010-024-02181-5 · Cited by 48
“There is a great potential to save lives and maintain patients’ quality of life by recognizing and treating sepsis earlier [2–4].”
BackgroundHospital-Acquired Pneumonia in a Multipurpose Intensive Care Unit: One-Year Prospective Study
Costa, R. D., Baptista, J. P., Freitas, R., & Martins, P. (2019) · Acta Médica Portuguesa · doi:10.20344/amp.11607 · Cited by 34
Lacquaniti, A., Ceresa, F., Campo, S., Barbera, G., Caruso, D., Palazzo, E., Patanè, F., & Monardo, P. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165193 · Cited by 30
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
Brunkhorst, F. M., Adamzik, M., Axer, H., Bauer, M. W., Bode, C., Bone, H.-G., Brenner, T., Bucher, M., David, S., Dietrich, M., et al. (2025) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-025-01317-1 · Cited by 47
Self-citationEmergency medicine updates: Management of sepsis and septic shock
Long, B., & Gottlieb, M. A. (2025) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2025.01.054 · Cited by 34
Quality indicators in intensive care medicine for Germany - fourth edition 2022
Kumpf, O., Assenheimer, M., Bloos, F., Brauchle, M., Braun, J.-P., Brinkmann, A., Czorlich, P., Dame, C., Dubb, R., Gahn, G., et al. (2023) · German medical science · doi:10.3205/000324 · Cited by 44
Self-citationSevere infections caused by difficult-to-treat Gram-negative bacteria
Dettori, S., Portunato, F., Vena, A., Giacobbe, D. R., & Bassetti, M. (2023) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001074 · Cited by 36
Tabah, A., Lipman, J., Barbier, F., Buetti, N., Timsit, J., & on behalf of the ESCMID Study Group for Infections in Critically Ill Patients—ESGCIP (2022) · Antibiotics · doi:10.3390/antibiotics11030362 · Cited by 39
“In the evaluation of a multifaceted intervention to decrease sepsis mortality in a group of 40 German hospitals, Bloos and colleagues report an increase in the risk of death of patients with sepsis or septic shock of 2% for each hour of delay of antimicrobial therapy and 1% for each hour of delay in source control [11…”
BackgroundChiriac, U., Richter, D., Frey, O. R., Röhr, A. C., Helbig, S., Preisenberger, J., Hagel, S., Roberts, J. A., Weigand, M. A., & Brinkmann, A. (2021) · Antibiotics · doi:10.3390/antibiotics10060667 · Cited by 28
“Empirical antimicrobial therapy needs to be administered in a timely manner to critically ill patients with sepsis and septic shock to reduce mortality [1,2].”
BackgroundA cytokine/PTX3 prognostic index as a predictor of mortality in sepsis
Davoudian, S., Piovani, D., Desai, A., Mapelli, S. N., Leone, R., Sironi, M., Valentino, S., Silva-Gomes, R., Stravalaci, M., Asgari, F., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.979232 · Cited by 27
“Age, median [Q1-Q3] 70 [57-81] 78 [70-84] 78 [71-85] 0.”
Wolfertz, N., Böhm, L., Keitel, V., Hannappel, O., Kümpers, P., Bernhard, M., & Michael, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.997992 · Cited by 25
Schwarzkopf, D., Fleischmann-Struzek, C., Rüddel, H., Reinhart, K., & Thomas-Rüddel, D. O. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194371 · Cited by 25
Self-citationBrinkmann, A., Röhr, A. C., Frey, O. R., Krüger, W. A., Brenner, T., Richter, D., Bodmann, K. ‐., Kresken, M., & Grabein, B. (2018) · Der Anaesthesist · doi:10.1007/s00101-018-0512-8 · Cited by 25
Rose, N., Matthäus‐Krämer, C., Schwarzkopf, D., Scherag, A., Born, S., Reinhart, K., & Fleischmann-Struzek, C. (2021) · BMC Public Health · doi:10.1186/s12889-021-11629-4 · Cited by 27
Self-citationThomas-Rüddel, D. O., Fröhlich, H., Schwarzkopf, D., Bloos, F., & Rießen, R. (2023) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-023-01037-4 · Cited by 35
Self-citationHildebrand, D., Decker, S., Koch, C., Schmitt, F. C. F., Ruhrmann, S., Schneck, E., Sander, M., Weigand, M. A., Brenner, T., Heeg, K. M., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00267 · Cited by 21
“However, the urgent clinical need for rapid diagnosis derives from the evidence that each hour of delayed antibiotic treatment increases mortality between 2 and 4% (Bloos et al., 2017; Seymour et al., 2017).”
Improved pathogen identification in sepsis or septic shock by clinical metagenomic sequencing
Brenner, T., Decker, S., Vainshtein, Y., Grumaz, S., Manoochehri, M., Feißt, M., Seidel-Glätzer, A., Pletz, M. W., Bracht, H., Berger, M. M., et al. (2025) · Journal of Infection · doi:10.1016/j.jinf.2025.106565 · Cited by 29
Self-citationAdäquate Antiinfektivatherapie: Bedeutung der individuellen Dosierung und Applikation
Brinkmann, A., Röhr, A. C., Koeberer, A., Fuchs, T., Krüger, W. A., König, C., Richter, D., Weigand, M. A., & Frey, O. R. (2018) · Der Anaesthesist · doi:10.1007/s00101-018-0443-4 · Cited by 19
“Es gibt inzwischen Hinweise aus der Literatur, dass eine prolongierte [42] und kontinuierliche Applikation von β-Lactam-Antibiotika nicht nur das Erreichen von PK/PD-Zielen erleichtert [8, 10] und die Gewebepenetration verbessert [13], sondern darüber hinaus auch die Sterblichkeit, v. a. bei schwer kranken Intensivpat…”
InfluentialChang, Y., Oh, J. H., Oh, D. K., Lee, S. Y., Hyun, D., Park, M. H., Lim, C.-M., the Korean Sepsis Alliance (KSA) investigators, Lim, C., Hong, S., et al. (2024) · Critical Care · doi:10.1186/s13054-024-05151-3 · Cited by 22
Montravers, P., Assadi, M., & Gouél‐Cheron, A. (2020) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000805 · Cited by 21
Bacterial sepsis: Diagnostics and calculated antibiotic therapy
Richter, D., Heininger, A., Brenner, T., Hochreiter, M., Bernhard, M., Briegel, J., Dubler, S., Grabein, B., Hecker, A., Krüger, W. A., et al. (2018) · Der Anaesthesist · doi:10.1007/s00101-017-0396-z · Cited by 22
“Delayedtreatment of the source infection was also associated with an increase in mortality of 1% per hour [106].”
BackgroundRecommendations for antibiotic selection for severe nosocomial infections
Mensa, J., Barberán, J., Ferrer, R., Borges-Sa, M., Sedes, P. R., Maseda, E., Oliver, A., Marco, F., Adàlia, R., Aguilar, G., et al. (2021) · Revista Española de Quimioterapia · doi:10.37201/req/126.2021 · Cited by 22
Aminoglycosides in critically ill patients: which dosing regimens for which pathogens?
Marsot, A., Hraiech, S., Cassir, N., Daviet, F., Parzy, G., Blin, O., Papazian, L., & Guilhaumou, R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106124 · Cited by 18
Duan, L.-W., Qu, J., Wan, J., Xu, Y.-H., Shan, Y., Wu, L.-X., Zheng, J., Jiang, W., Chen, Q., Zhu, Y., et al. (2020) · World Journal of Emergency Medicine · doi:10.5847/wjem.j.1920-8642.2021.01.005 · Cited by 16
Cook, D. J., Rutherford, W. B., Scales, D. C., Adhikari, N. K. J., & Cuthbertson, B. H. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004885 · Cited by 14
Arulappen, A. L., Danial, M., Ng, L. W., & Teoh, J. C. (2022) · Antibiotics · doi:10.3390/antibiotics11091202 · Cited by 14
“involving patients with severe sepsis and septic shock in 165 ICUs concluded that the time of administration was positively associated with the mortality rate [8].”
BackgroundTrial of antibiotic restraint in presumed pneumonia: A Surgical Infection Society multicenter pilot
Guidry, C. A., Beyene, R. T., Watson, C. M., Sawyer, R. G., Chollet‐Hinton, L., Simpson, S. Q., Atchison, L., Derickson, M. J., Cooper, L., Pennington, G. P., et al. (2022) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000003839 · Cited by 14
“Guidry et al. J Trauma Acute Care Surg Volume 94, Number 2 Bloos et al.34 performed a cluster-randomized educational sepsis intervention focused on the timing and management of empiric antibiotics but ultimately failed to demonstrate a difference in the timing of antibiotics.”
BackgroundRichter, D., Dietrich, M., Lalev, L. D., Schmitt, F. C. F., Fiedler, M. O., Bruckner, T. M., Störzinger, D., Chiriac, U., Klein, S., Hackert, T., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10060687 · Cited by 16
“We would like to argue that these effects are in line with prospective investigations highlighting the role of focus control and adequate antibiotic treatment [3, 5, 6, 43, 44].”
ResultSchwarzkopf, D., Rüddel, H., Gründling, M., Putensen, C., & Reinhart, K. (2018) · Implementation Science · doi:10.1186/s13012-017-0706-5 · Cited by 16
“The MEDUSA trial (Medical EDUcation for sepsis Source control and Antibiotics, ClinicalTrials.gov identifier NCT01187134) was the first multi-center quality initiative for reducing mortality among inpatient cases with severe sepsis in Germany [12, 29].”
BackgroundInfluentialSelf-citationWang, L., Tian, W., Zhang, W., Wen, D., Yang, S., Wang, J., Han, X., Wang, J., Ding, W., Wang, L., et al. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119716 · Cited by 14
Sun, Q., Teng, R., Shi, Q., Liu, Y., Cai, X., Yang, B., Cao, Q., Shu, C., Mei, X., Zeng, W., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70297 · Cited by 15
Schwarzkopf, D., Bloos, F., Meißner, W., Rüddel, H., Thomas-Rüddel, D. O., & Wedding, U. (2024) · Healthcare · doi:10.3390/healthcare12060602 · Cited by 22
“This is a substudy of a cluster randomized controlled trial, which aimed to improve acute sepsis care (Medical Education for Sepsis Source Control and Antibiotics, MEDUSA, ClinicalTrials.gov identifier NCT01187134) [28].”
BackgroundSelf-citationKopczynska, M., Sharif, B., Unwin, H., Lynch, J., Forrester, A., Zeicu, C., Cleaver, S., Kulikouskaya, S., Chandy, T., Ang, E., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091337 · Cited by 12
“Our findings, that broad spectrum antibiotic use was common without appropriate microbiological investigations is alarming, especially as it is corroborated by international data [4,20].”
ResultLu, Z., & Zhou, L. (2024) · Entertainment Computing · doi:10.1016/j.entcom.2024.100786 · Cited by 11
Evaluation of continuous ampicillin/sulbactam infusion in critically ill patients
Passon, S. G., Schmidt, A. R., Wittmann, M., Velten, M., & Baehner, T. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121567 · Cited by 12
Optimized Treatment of Nosocomial Peritonitis
Waele, J. J. D., Coccolini, F., Lagunes, L., Maseda, E., Rausei, S., Perez, I. R., Θεοδωρακοπούλου, Μ., & Arvaniti, K. (2023) · Antibiotics · doi:10.3390/antibiotics12121711 · Cited by 15
“When the selected strategy is not adapted to the patient, the disease, and the expertise of the operator, the clinical management becomes more complex [92].”
BackgroundIndividualized antibiotic therapy in the treatment of severe infections
Annoni, F., Grimaldi, D., & Taccone, F. S. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1696192 · Cited by 12
Timing and Spectrum of Antibiotic Treatment for Suspected Sepsis and Septic Shock
Pak, T. R., Rhee, C., & Klompas, M. (2022) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2022.08.001 · Cited by 13
Al-Kader, D. A., Anwar, S., Hussaini, H., Amaowei, E. E. J., Rasuli, S. F., Hussain, N., Kaddo, S., & Memon, A. (2022) · Cureus · doi:10.7759/cureus.32405 · Cited by 13
Sepsis hysteria: facts versus fiction
Reinhart, K., Daniels, R., Schwarzkopf, D., & Kissoon, N. “. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06001-w · Cited by 11
Self-citationSOP Individuelle Dosierung und Applikation von Antiinfektiva auf der Intensivstation
Röhr, A. C., Koeberer, A., Fuchs, T., von Freyberg, P., Frey, O. R., & Brinkmann, A. (2018) · Intensivmedizin up2date · doi:10.1055/a-0626-8184 · Cited by 9
“Es ist in der aktuellen Literatur sicher belegt, dass eine adäquate und vor allem zeitgerechte antiinfektive Therapie die Sterblichkeit von Intensivpatienten mit schweren lebensbedrohlichen Infektionen signifikant reduziert [1].”
BackgroundFocus on sepsis: new concepts and findings in sepsis care
Timsit, J., Ruppé, É., & Ferrer, R. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5406-3 · Cited by 10
Early Empirical Use of Broad-Spectrum Antibiotics in Sepsis
Chang, J. L., Pearson, J. C., & Rhee, C. (2022) · Current Infectious Disease Reports · doi:10.1007/s11908-022-00777-2 · Cited by 13
Tabah, A., Waele, J. J. D., Kai, N. S. Y., Aslan, A. T., Buetti, N., Timsit, J., Ballard, E. L., Eriksson, L., Laupland, K. B., & Lipman, J. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-08026-5 · Cited by 11
“Inconsistent timing definitions bias the prognostic implications of timely SC, as shown by the Medusa trial, linking each hour of delay to a 1% increase in day-28 mortality, and the ABSES cohort, reporting higher mortality with SC performed too early ( 2 h) vs. 2–6 h [43, 44].”
Antibiotics in the first hour: is there new evidence?
Dupuis, C., & Timsit, J. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1810567 · Cited by 7
Schwarzkopf, D., Rüddel, H., Brinkmann, A., Fleischmann-Struzek, C., Friedrich, M. E., Glas, M., Gogoll, C., Gründling, M., Meybohm, P., Pletz, M. W., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.882340 · Cited by 12
Self-citationLagarde, C., Bouras, M., Floch, R. L., Hourmant, Y., Grillot, N., Bourdiol, A., Mahe, P. J., Latte, D. D. D., Grégoire, M., Dailly, É., et al. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad094 · Cited by 8
Exploring the content and delivery of feedback facilitation co-interventions: a systematic review
Sykes, M., Rosenberg-Yunger, Z. R. S., Quigley, M., Gupta, L., Thomas, O., Robinson, L., Caulfield, K., Ivers, N., & Alderson, S. (2024) · Implementation Science · doi:10.1186/s13012-024-01365-9 · Cited by 7
Kalkulierte parenterale Initialtherapie bakterieller Infektionen: Sepsis
Bodmann, K., Höhl, R., Krüger, W. A., Grabein, B., & Graninger, W. (2020) · GMS infectious diseases · doi:10.3205/id000053 · Cited by 7
Schwarzkopf, D., Matthäus‐Krämer, C., Thomas-Rüddel, D. O., Rüddel, H., Poidinger, B., Bach, F., Gerlach, H., Gründling, M., Lindner, M., Scheer, C., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07915-9 · Cited by 7
Self-citationQiu, Y.-G., Hu, Q., Xu, W.-X., Wang, W. J., Zhang, H., Zhong, Y.-J., Li, J., Qu, Q., & Qu, J. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002812 · Cited by 8
“Selecting the appropriate antibiotic based on the bacteria’s activity profile is crucial, but the efficacy of treat-ment and complete elimination of pathogens also depends on the proper administration regimen, including dosage and frequency [8] .”
Vallés, J., Díaz, E., Oliva, J. C., Martínez, M., Navas, A., Mesquida, J., Gruartmoner, G., de Haro, C., Mestre, J., Guía, C., et al. (2020) · Medicina Intensiva (English Edition) · doi:10.1016/j.medin.2020.05.008 · Cited by 7
Debbeler, L. J., Pohrt, A., Fleischmann-Struzek, C., Schwarzkopf, D., Born, S., Reinhart, K., & Wegwarth, O. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133659 · Cited by 7
Self-citation
Metadata
- Authors
- for the MEDUSA study group, Bloos, F., Rüddel, H., Thomas-Rüddel, D., Schwarzkopf, D., Pausch, C., Harbarth, S., Schreiber, T., Gründling, M., Marshall, J., Simon, P., Levy, M. M., Weiss, M., Weyland, A., Gerlach, H., Schürholz, T., Engel, C., Matthäus-Krämer, C., Scheer, C., Bach, F., Riessen, R., Poidinger, B., Dey, K., Weiler, N., Meier-Hellmann, A., Häberle, H. H., Wöbker, G., Kaisers, U. X., & Reinhart, K.
- Affiliations
- Jena University Hospital (DE)
- University Hospital of Geneva (CH)
- Universitätsmedizin Greifswald (DE)
- St. Michael's Hospital (CA)
- Brown University (US)
- Carl von Ossietzky Universität Oldenburg (DE)
- Vivantes Klinikum (DE)
- Universitätsklinikum Aachen (DE)
- Universitätsklinikum Tübingen (DE)
- University Hospital Schleswig-Holstein (DE)
- Helios Universitätsklinikum Wuppertal (DE)
- University Hospital Leipzig (DE)
- Corresponding author
- Reinhart, Konrad
- ORCID
- Bloos, Frank
- Rüddel, Hendrik
- Thomas-Rüddel, Daniel
- Schwarzkopf, Daniel
- Pausch, Christine
- Harbarth, Stephan
- Schreiber, Torsten
- Gründling, Matthias
- Marshall, John
- Simon, Philipp
- Levy, Mitchell M.
- Weiss, Manfred
- Weyland, Andreas
- Gerlach, Herwig
- Engel, Christoph
- Scheer, Christian
- Riessen, Reimer
- Wöbker, Gabriele
- Kaisers, Udo X.
- Reinhart, Konrad
- Venue
- Intensive Care Medicine
- Published
- 2017-05-02
- Volume
- 43
- Issue
- 11
- Pages
- 1602-1612
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2610730883
- Semantic Scholar
- 3694fb60fd764735ba686dcd91d09e7213aa4b15
- Cited by
- 200
- References
- 39
- Citations by year
- 2026: 10 · 2025: 21 · 2024: 23 · 2023: 23 · 2022: 27 · 2021: 26 · 2020: 19 · 2019: 25 · 2018: 22 · 2017: 4
- FWCI
- 14.99
- Type
- journal article
- Language
- en
- Open access
- Licence
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- OPUS (Augsburg University) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Bundesministerium für Bildung und Forschung (FKZ 01EO1002)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Health Professions › General Health Professions › Health Policy Implementation Science
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- sepsis, septic shock, sepsis mortality, antimicrobial stewardship, continuing medical education, audit and feedback, quality improvement teams, source control, guideline adherence, 28-day mortality
- MeSH terms
- Aged, Anti-Bacterial Agents, Education, Continuing, Female, Humans, Intensive Care Units, Length of Stay, Male, Middle Aged, Prospective Studies, Risk Factors, Shock, Septic, Hospital Mortality, Guideline Adherence, Intention to Treat Analysis, Quality Improvement, Time-to-Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.